Page 20 - Pharmaceutical
Cipla and Russia's Nacimbio join hands for HIV and hepatitis C drugs
As per the agreement, two sides will collaborate to set up a facility in Russia for the production of antiretroviral drugs
 "Cipla and Russia's Nacimbio join hands for HIV and hepatitis C drugs")
Zydus Cadila partners with Eczacibasi to tap Turkish biosimilar market
As per the deal, Zydus will market biosimilars, which are currently unavailable in Turkey especially for the treatment of cancer
 "Zydus Cadila partners with Eczacibasi to tap Turkish biosimilar market")
US specialty pharma firms to change their M&A strategies: Moody's
The slowdown in acquisitions, along with the scrutiny on aggressive price increases, will force many specialty pharmaceutical companies to shift their growth strategies, says the ratings agency
 "US specialty pharma firms to change their M&A strategies: Moody's")
Gelatine capsules technically better than HPMC, says PHD Chamber to DCGI
The current annual installed capacity of HPMC is around 2 billion compared to gelatine's 120 billion, hence replacing HPMC with gelatine is not a feasible option
 "Gelatine capsules technically better than HPMC, says PHD Chamber to DCGI")
Chaturbhuj Pharmaceutical to commercialise ayurvedic diabetes drug
The company has signed licensing agreement with National Research Development Corporation (NRDC) for Ayush-82, developed by Central Council for Research in Ayurvedic Sciences
 "Chaturbhuj Pharmaceutical to commercialise ayurvedic diabetes drug")
Teva, Allergan agree to sell 8 products to Dr Reddy's for $350 mn
The acquired portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business
 "Teva, Allergan agree to sell 8 products to Dr Reddy's for $350 mn")
Sun Pharma's OTC business forays into dermatology
The business, which current markets dietary supplements, analgesics and antacids, has rolled out Suncros, a sunscreen product
Zydus Cadila to start phase 2 trials of saroglitazar for liver disease
The company has received US FDA approval to initiate phase 2 clinical trials of saroglitazar in patients with non-alcoholic steatohepatitis (NASH), a liver disease, in the US
Eisai and Novartis to co-promote anticancer drugs in US
Two companies will promote Eisai's anticancer agent Lenvima in combination with everolimus as treatment for advanced renal cell carcinoma in the US
Lupin receives US FDA's nod for antifungal drug voriconazole
The company has received approval for voriconazole tablet (50 mg & 200 mg) and oral suspension (40 mg/mL) - generic versions of PF Prism CV's Vfend tablet and oral suspension
 "Lupin receives US FDA's nod for antifungal drug voriconazole")
Frontida BioPharm buys Sun Pharma's two US facilities
Sun Pharma has sold its two oral solid dosage manufacturing facilities located at Philadelphia and Aurora, along with 15 related products, to Frontida BioPharm
 "Frontida BioPharm buys Sun Pharma's two US facilities")
Dr Reddy's launches psoriasis drug Sernivo in US
Sernivo (betamethasone dipropionate) spray is used for the treatment of mild to moderate plaque psoriasis
Jubilant Biosys inks license pact with US-based Checkpoint for cancer drug
As per the deal, Jubilant Biosys will receive an upfront payment of $ 2 mn and contingent preclinical, clinical and regulatory payments including commercial milestones totalling up to $ 180 mn
 "Jubilant Biosys inks license pact with US-based Checkpoint for cancer drug")
Dr Reddy's acquires 6 OTC brands from Ducere Pharma in US
With this, the Hyderabad based pharma major has entered the branded consumer health market in the US
 "Dr Reddy's acquires 6 OTC brands from Ducere Pharma in US")
Ajanta Pharma receives US FDA approval of antifungal voriconazole tablet
Voriconazole is the generic version of Vfend, manufactured by PF Prism CV
 "Ajanta Pharma receives US FDA approval of antifungal voriconazole tablet")
Novartis to create two units to focus on pharma and oncology
The new structure reflects the importance of oncology to Novartis following the successful integration of the oncology assets acquired from GSK
 "Novartis to create two units to focus on pharma and oncology")
Suven Life bags product patents for NCEs in Australia, Eurasia, Israel and US
The patents have been granted to the company's new chemical entities (NCEs) for CNS therapy through mechanism of action - H3 inverse agonist
Ajanta Pharma receives US FDA nod for migraine drug zolmitriptan
Zolmitriptan tablet is a generic version of Zomig, a registered trademark of AstraZeneca
 "Ajanta Pharma receives US FDA nod for migraine drug zolmitriptan")
India and Japan to seek regulatory collaboration for medical products
The Japan has extended support to Government of India for Indian regulators' skill enhancement through its Asia Training Centre
 "India and Japan to seek regulatory collaboration for medical products")
Pharma exports to witness a sharp fall as value of off-patent drugs declines
While the exports witnessed growth of 19 percent in the last decade, it is expected to decline sharply to 10-12 percent annually over the next 5 years, says a Crisil Research report
 "Pharma exports to witness a sharp fall as value of off-patent drugs declines")